Stockscreener 앱 받기
8.71
1.63%
0.14
Fennec Pharmaceuticals Inc 주식(FENC)의 최신 뉴스
What analysts say about Fennec Pharmaceuticals Inc. stockUnrivaled growth potential - jammulinksnews.com
Fennec Pharmaceuticals Inc. Stock Analysis and ForecastTriple returns potential - Autocar Professional
Is Fennec Pharmaceuticals Inc. a good long term investmentHigh-profit trading signals - jammulinksnews.com
How To Trade (FENC) - news.stocktradersdaily.com
What drives Fennec Pharmaceuticals Inc. stock priceJaw-dropping returns - jammulinksnews.com
Why Fennec Pharmaceuticals Inc. stock attracts strong analyst attentionFree Access to Investment Community - Newser
What makes Fennec Pharmaceuticals Inc. stock price move sharplyFree Elite Traders Group - Newser
(FENC) Long Term Investment Analysis - news.stocktradersdaily.com
Fennec Pharmaceuticals (TSE:FRX) Reaches New 52-Week High – Still a Buy? - Defense World
Long Term Trading Analysis for (FENC) - news.stocktradersdaily.com
Bank of America Corp DE Has $226,000 Stock Holdings in Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
Fennec's Pedmarqsi gets nod from U.K. regulators - MSN
(FENC) Investment Analysis and Advice - news.stocktradersdaily.com
Insider Sell: Rosty Raykov Sells 10,000 Shares of Fennec Pharmac - GuruFocus
Insider Sell: Rosty Raykov Sells 10,000 Shares of Fennec Pharmaceuticals Inc (FENC) - GuruFocus
Fennec Pharmaceuticals elects board members, shareholders approve proposals By Investing.com - Investing.com South Africa
Fennec Pharmaceuticals elects board members, shareholders approve proposals - Investing.com
Fennec Pharmaceuticals Approves Proposals at Shareholder Meeting - TipRanks
Fennec Announces Results of Annual Meeting - TradingView
Northern Trust Corp Sells 2,976 Shares of Fennec Pharmaceuticals Inc (NASDAQ:FENC) - Defense World
FENC Meeting Scheduled in Toronto Hosted by Craig-Hallum | FENC Stock News - GuruFocus
Indian Pharma Co. Hit With Patent Suit Over Fennec's Cancer Drug - Law360
Fennec Pharmaceuticals Inc (NASDAQ:FENC) Shares Acquired by BNP Paribas Financial Markets - Defense World
Q2 EPS Estimate for Fennec Pharmaceuticals Raised by Analyst - Defense World
HC Wainwright Brokers Increase Earnings Estimates for FENC - Defense World
FY2026 Earnings Estimate for TSE:FRX Issued By HC Wainwright - Defense World
Research Analysts Offer Predictions for FENC FY2026 Earnings - Defense World
Fennec Pharmaceuticals (NASDAQ:FENC) Earns Buy Rating from HC Wainwright - Defense World
Don't Ignore The Insider Selling In Fennec Pharmaceuticals - simplywall.st
5.00%
0.36%
자본화:
|
볼륨(24시간):